Literature DB >> 25987581

Quality of life and clinical characteristics in a nonselected sample of patients with schizophrenia.

Clara R Medici1, Claus H Vestergaard2, Peter Hjorth2, Mette V Hansen2, Jan W D Shanmuganathan2, Anne G Viuff3, Povl Munk-Jørgensen4.   

Abstract

BACKGROUND: Patients with schizophrenia experience low quality of life (QOL). AIMS: To examine QOL in these patients and the relation between QOL and illness duration, adjusted daily doses (ADDs) of antipsychotics, body mass index (BMI), waist circumference and smoking.
METHODS: In this naturalistic, cross-sectional study, 82 patients were interviewed about smoking habits. Patients completed a QOL questionnaire (World Health Organization Quality of Life-Bref) consisting of physical, psychological, social and environmental domains and had height, weight and waist circumference measured. The characteristics and QOL were correlated using multiple regression analysis.
RESULTS: QOL was significantly lower in the patients than in the general population (p < .01). In first-ever diagnosed patients, QOL was associated with BMI (regression coefficient (RC): physical -0.73, psychological -1.44 and environmental -0.55; all p < .05), ADD (RC: physical 3.71, psychological 4.37 and environmental 2.94; all p < .10) and smoking (RC: physical -0.69; p < .01). In the long-term ill patients, QOL was associated with BMI (RC: physical -1.19 and psychological -1.28; all p < .05) and illness duration (RC: physical 1.38; p < .05).
CONCLUSION: Patients experienced low QOL. Lower QOL was associated with high BMI, low ADD and smoking in first-ever diagnosed patients and with high BMI and short illness duration in long-term ill patients.
© The Author(s) 2015.

Entities:  

Keywords:  Schizophrenia; antipsychotic agents; body mass index; duration of illness; quality of life; smoking

Mesh:

Substances:

Year:  2015        PMID: 25987581     DOI: 10.1177/0020764015585330

Source DB:  PubMed          Journal:  Int J Soc Psychiatry        ISSN: 0020-7640


  4 in total

1.  Development of a mental health recovery module for the WHOQOL.

Authors:  Melissa J Rowthorn; D Rex Billington; Christian U Krägeloh; Jason Landon; Oleg N Medvedev
Journal:  Qual Life Res       Date:  2019-08-10       Impact factor: 4.147

2.  Antipsychotic Treatment Experiences of People with Schizophrenia: Patient Perspectives from an Online Survey.

Authors:  Michael J Doane; Martha Sajatovic; Peter J Weiden; Amy K O'Sullivan; Stephen Maher; Jakob B Bjorner; Asia Sikora Kessler; Julia Carpenter-Conlin; Leona Bessonova; Dawn I Velligan
Journal:  Patient Prefer Adherence       Date:  2020-10-28       Impact factor: 2.711

3.  Qualities of Life of Patients with Psychotic Disorders and Their Family Caregivers: Comparison between Hospitalised and Community-Based Treatment in Beijing, China.

Authors:  Lizheng Guan; Yingqiang Xiang; Xin Ma; Yongzhen Weng; Wannian Liang
Journal:  PLoS One       Date:  2016-11-21       Impact factor: 3.240

4.  Animal Assisted Therapy (AAT) Program As a Useful Adjunct to Conventional Psychosocial Rehabilitation for Patients with Schizophrenia: Results of a Small-scale Randomized Controlled Trial.

Authors:  Paula Calvo; Joan R Fortuny; Sergio Guzmán; Cristina Macías; Jonathan Bowen; María L García; Olivia Orejas; Ferran Molins; Asta Tvarijonaviciute; José J Cerón; Antoni Bulbena; Jaume Fatjó
Journal:  Front Psychol       Date:  2016-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.